Clinical Trial to access efficacy of Amlavetas (Garcinia pedunculata) in dissolution of Gall bladder Stones.

Standardization and Single Arm Clinical Trial of AMLAVETAS (Garcinia pedunculata Roxb.) to assess its BHEDAN KARMA (AGRYA- Dravya of choice) in PITTASHAYASTHA ASHMARI (Silent Cholelithiasis)

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/04/032620

Enrollment

Registered

2021-04-07

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K802- Calculus of gallbladder without cholecystitis

Interventions

Intervention1: Amlavetas (Garcinia pedunculata Roxb.) Churna (powder): Dose:- 2gm to 6gm/day Time of Medication:- Twice a day Anupan(medicine with):- Koshna Jal Kaal:- Saman (Before Half Meal) Dur

Eligibility

Inclusion criteria

Inclusion criteria: 1.Volunteers with SILENT Gall Calculi. 2. Acute cholecystitis with Gall bladder calculi; subsided with conservative management and Patient not willing for surgery. 3. Gall Calculi of size 4. Patients of Cholelithiasis undergo any type of treatment with no or suboptimal relief.

Exclusion criteria

Exclusion criteria: 1. Individuals having Gall bladder Calculi with any acute conditions. 2. Individuals having multiple Gall bladder Calculi more than Five. 3. Individuals having Gall bladder Calculi near bile duct. 4. Pregnancy. 5. Individuals with major systemic illness e.g. Carcinoma, AIDS, TB, DM. 6. Gall bladder calculi adhered to the wall of Gall bladder.

Design outcomes

Primary

Measure	Time frame
Reduction in size of Gall Stones.Timepoint: 3 Months	—

Secondary

Measure	Time frame
1.Reduction in Pain, nausea, vomiting, flatulence and dyspepsia. 2.Change in values of Lipid profile.Timepoint: 3 Months	—

Countries

India

Contacts

Public ContactVdNeha Shivde

Sumatibhai Shah Ayurvedic Mahavidyalaya, Hadapsar, Pune

drkoresharayu@gmail.com9970356590

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026